Authors:
Malina, J
Novakova, O
Keppler, BK
Alessio, E
Brabec, V
Citation: J. Malina et al., Biophysical analysis of natural, double-helical DNA modified by anticancerheterocyclic complexes of ruthenium(lll) in cell-free media, J BIOL I CH, 6(4), 2001, pp. 435-445
Citation: C. Hofr et al., Thermodynamic properties of duplex DNA containing a site-specific d(GpG) intrastrand crosslink formed by an antitumor dinuclear platinum complex, NUCL ACID R, 29(10), 2001, pp. 2034-2040
Authors:
Missura, M
Buterin, T
Hindges, R
Hubscher, U
Kasparkova, J
Brabec, V
Naegeli, H
Citation: M. Missura et al., Double-check probing of DNA bending and unwinding by XPA-RPA: an architectural function in DNA repair, EMBO J, 20(13), 2001, pp. 3554-3564
Authors:
Zehnulova, J
Kasparkova, J
Farrell, N
Brabec, V
Citation: J. Zehnulova et al., Conformation, recognition by high mobility group domain proteins, and nucleotide excision repair of DNA intrastrand cross-links of novel antitumor trinuclear platinum complex BBR3464, J BIOL CHEM, 276(25), 2001, pp. 22191-22199
Citation: J. Kasparkova et al., Different recognition of DNA modified by antitumor cisplatin and its clinically ineffective trans isomer by tumor suppressor protein p53, J BIOL CHEM, 276(19), 2001, pp. 16064-16069
Citation: C. Hofr et V. Brabec, Thermal and thermodynamic properties of duplex DNA containing site-specific interstrand cross-link of antitumor cisplatin or its clinically ineffective trans isomer, J BIOL CHEM, 276(13), 2001, pp. 9655-9661
Authors:
Dragoun, O
Spalek, A
Rysavy, M
Kovalik, A
Yakushev, EA
Brabec, V
Frana, J
Venos, D
Citation: O. Dragoun et al., Improved methods of measurement and analysis of conversion electron and beta-particle spectra, APPL RAD IS, 52(3), 2000, pp. 387-391
Authors:
Brabec, V
Neplechova, K
Kasparkova, J
Farrell, N
Citation: V. Brabec et al., Steric control of DNA interstrand cross-link sites of trans platinum complexes: specificity can be dictated by planar nonleaving groups, J BIOL I CH, 5(3), 2000, pp. 364-368
Citation: J. Kasparkova et al., Sequence specificity, conformation, and recognition by HMG1 protein of major DNA interstrand cross-links of antitumor dinuclear platinum complexes, J BIOL CHEM, 275(21), 2000, pp. 15789-15798
Authors:
Malina, J
Hofr, C
Maresca, L
Natile, G
Brabec, V
Citation: J. Malina et al., DNA interactions of antitumor cisplatin analogs containing enantiomeric amine ligands, BIOPHYS J, 78(4), 2000, pp. 2008-2021
Citation: H. Kostrhunova et V. Brabec, Conformational analysis of site-specific DNA cross-links of cisplatin-distamycin conjugates, BIOCHEM, 39(41), 2000, pp. 12639-12649
Citation: O. Novakova et al., Modification of natural, double-helical DNA by antitumor cis- and trans-[Cl-2(Me2SO4)(4)Ru] in cell-free media, BIOCH PHARM, 60(12), 2000, pp. 1761-1771
Authors:
McGregor, TD
Balcarova, Z
Qu, Y
Tran, MC
Zaludova, R
Brabec, V
Farrell, N
Citation: Td. Mcgregor et al., Sequence-dependent conformational changes in DNA induced by polynuclear platinum complexes, J INORG BIO, 77(1-2), 1999, pp. 43-46
Citation: H. Loskotova et V. Brabec, DNA interactions of cisplatin tethered to the DNA minor groove binder distamycin, EUR J BIOCH, 266(2), 1999, pp. 392-402
Authors:
Kasparkova, J
Novakova, O
Vrana, O
Farrell, N
Brabec, V
Citation: J. Kasparkova et al., Effect of geometric isomerism in dinuclear platinum antitumor complexes onDNA interstrand cross-linking, BIOCHEM, 38(34), 1999, pp. 10997-11005
Authors:
Brabec, V
Kasparkova, J
Vrana, O
Novakova, O
Cox, JW
Qu, Y
Farrell, N
Citation: V. Brabec et al., DNA modifications by a novel bifunctional trinuclear platinum Phase I anticancer agent, BIOCHEM, 38(21), 1999, pp. 6781-6790